Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors
Goebel, L., Kirschner, T., Koska, S., Rai, A., Janning, P., Maffini, S., Vatheuer, H., Czodrowski, P., Goody, R.S., Mueller, M.P., Rauh, D.To be published.